Literature DB >> 22302811

Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAβ mice.

Jan Klohs1, Christof Baltes, Felicitas Princz-Kranz, David Ratering, Roger M Nitsch, Irene Knuesel, Markus Rudin.   

Abstract

Amyloid-β (Aβ) deposition in the cerebral vasculature is accompanied by remodeling which has a profound influence on vascular integrity and function. In the current study we have quantitatively assessed the age-dependent changes of the cortical vasculature in the arcAβ model of cerebral amyloidosis. To estimate the density of the cortical microvasculature in vivo, we used contrast-enhanced magnetic resonance microangiography (CE-μMRA). Three-dimensional gradient echo datasets with 60 μm isotropic resolution were acquired in 4- and 24-month-old arcAβ mice and compared with wild-type (wt) control mice of the same age before and after administration of superparamagnetic iron oxide nanoparticles. After segmentation of the cortical vasculature from difference images, an automated algorithm was applied for assessing the number and size distribution of intracortical vessels. With CE-μMRA, cerebral arteries and veins with a diameter of less than the nominal pixel resolution (60 μm) can be visualized. A significant age-dependent reduction in the number of functional intracortical microvessels (radii of 20-80 μm) has been observed in 24-month-old arcAβ mice compared with age-matched wt mice, whereas there was no difference between transgenic and wt mice of 4 months of age. Immunohistochemistry demonstrated strong fibrinogen and Aβ deposition in small- and medium-sized vessels, but not in large cerebral arteries, of 24-month-old arcAβ mice. The reduced density of transcortical vessels may thus be attributed to impaired perfusion and vascular occlusion caused by deposition of Aβ and fibrin. The study demonstrated that remodeling of the cerebrovasculature can be monitored noninvasively with CE-μMRA in mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302811      PMCID: PMC6703349          DOI: 10.1523/JNEUROSCI.5626-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  34 in total

Review 1.  Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease.

Authors:  Hyung J Ahn; Zu-Lin Chen; Daria Zamolodchikov; Erin H Norris; Sidney Strickland
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

Review 2.  On the Usage of Brain Atlases in Neuroimaging Research.

Authors:  Andreas Hess; Rukun Hinz; Georgios A Keliris; Philipp Boehm-Sturm
Journal:  Mol Imaging Biol       Date:  2018-10       Impact factor: 3.488

3.  Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration.

Authors:  Marta Cortes-Canteli; Larissa Mattei; Allison T Richards; Erin H Norris; Sidney Strickland
Journal:  Neurobiol Aging       Date:  2014-10-31       Impact factor: 4.673

4.  Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.

Authors:  Pradeep K Singh; Masanori Kawasaki; Hanna E Berk-Rauch; Goushi Nishida; Takeshi Yamasaki; Michael A Foley; Erin H Norris; Sidney Strickland; Kazuyoshi Aso; Hyung Jin Ahn
Journal:  Biochemistry       Date:  2018-02-09       Impact factor: 3.162

5.  Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.

Authors:  Y C Chung; A Kruyer; Y Yao; E Feierman; A Richards; S Strickland; E H Norris
Journal:  J Thromb Haemost       Date:  2016-06-13       Impact factor: 5.824

Review 6.  Fibrinogen and altered hemostasis in Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Daria Zamolodchikov; Hyung Jin Ahn; Sidney Strickland; Erin H Norris
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 7.  Rodent Models of Vascular Cognitive Impairment.

Authors:  Qing-Zhang Tuo; Jin-Jun Zou; Peng Lei
Journal:  J Mol Neurosci       Date:  2020-10-27       Impact factor: 3.444

8.  Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging.

Authors:  Jan Klohs; Igna Wojtyna Politano; Andreas Deistung; Joanes Grandjean; Anna Drewek; Marco Dominietto; Ruth Keist; Ferdinand Schweser; Jürgen R Reichenbach; Roger M Nitsch; Irene Knuesel; Markus Rudin
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

9.  Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model.

Authors:  Stefanie Schreiber; Celine Zoe Bueche; Cornelia Garz; Holger Braun
Journal:  Exp Transl Stroke Med       Date:  2013-03-14

10.  Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.

Authors:  Sarah Westwood; Emanuela Leoni; Abdul Hye; Steven Lynham; Mizanur R Khondoker; Nicholas J Ashton; Steven J Kiddle; Alison L Baird; Ricardo Sainz-Fuertes; Rufina Leung; John Graf; Cristina Tan Hehir; David Baker; Cristina Cereda; Chantal Bazenet; Malcolm Ward; Madhav Thambisetty; Simon Lovestone
Journal:  J Alzheimers Dis       Date:  2016-03-29       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.